Our previous study demonstrated that IGFBP-3 induced G1 cell cycle arrest by inhibiting cyclin D1, cyclin D3, cyclin E, cyclin A, CDK2, CDK4, total and phospho-pRb, and increasing p21 and p16 in MCF-7 breast cancer cells17. Here, CDK4 is linked to breast cancer.